Cancer Drug Resistance (CDR) is an open access journal. When a paper is accepted for publication, authors are required to pay Article Processing Charges (APCs) to cover its editorial and production costs. The APCs for each submission is $2000. There are no additional charges based on color, length, figures, or other elements. For more details, please refer to OAE Publication Fees.